Headquartered in Australia, Noxopharm Limited (ASX: NOX) is a clinical...
AstraZeneca has agreed to sell the global commercial rights to In...
Merck, a leading science and technology company, announced an investme...
US based SunGen Pharma, a privately held specialty pharmaceutical comp...
A ‘digital twin’ of the human cardiovascular system will b...
Physicians and scientists at Rush University Medical Center,...
Inovio Pharmaceuticals, USA has announced the Coalition for Epidemic P...
GErman firms Evotec SE and Indivumed GmbH have announced that the comp...
AstraZeneca has announced that it will support UNICEF with a $12.5 mil...
Advanced BioMatrix has acquired the HyStem® line of products from ...
Roche has announced positive topline results from the pivotal Part 2 o...
IQVIA Holdings Inc. has been named to FORTUNE magazine’s “...
Ireland headquartered Horizon Therapeutics plc has announced that the ...
French firm Inotrem S.A., a biotechnology company specialized in the d...
MicroVention, Inc., a U.S. based subsidiary of Terumo and a global neu...
Roche today announced that the European Commission has granted conditi...
France based Seekyo, a privately-owned biotech start-up specializing i...
US based drug manufacturer Civica Rx (Civica, Inc.) has signed a ...
